文献速递眼底病与葡萄膜炎

视网膜与玻璃体疾病干预措施系统评价的可靠性评估

Evaluation of Systematic Reviews of Interventions for Retina and Vitreous Conditions.
PubMed 文献 · JAMA Ophthalmol · 2019-01-01

这项横断面研究评估了327篇视网膜与玻璃体疾病干预措施系统评价的可靠性,发现131篇(40.1%)可靠,196篇(59.9%)不可靠;不可靠最常见原因是缺乏全面文献检索的证据(149/196,76.0%)。作者认为多数系统评价不可靠,建议系统评价团队和指南制定者与信息专业人员合作。

要点

  • 327篇视网膜与玻璃体疾病系统评价中,40.1%可靠,59.9%不可靠。
  • 7种视网膜与玻璃体疾病均至少找到1篇可靠系统评价。
  • 不可靠最常见原因为缺乏全面文献检索证据(76.0%)。

核心结论

  • 研究结果提示,多数针对视网膜与玻璃体疾病干预措施的系统评价不可靠。
  • 系统评价团队和指南制定者应与信息专业人员合作,以应对检索不同资源所需的复杂多变的语法。

研究设计与样本

  • 横断面研究,纳入Cochrane Eyes and Vision United States Satellite数据库中的视网膜与玻璃体疾病干预措施系统评价。
  • 初步检索于2007年3月进行,最终更新于2018年7月完成。
  • 由2名研究助理独立提取数据,分歧通过讨论或由1名研究助理在资深团队成员核验下解决。

主要发现

  • 共识别327篇视网膜与玻璃体疾病系统评价,其中131篇(40.1%)分类为可靠,196篇(59.9%)分类为不可靠。
  • 7种视网膜与玻璃体疾病每种均至少找到1篇可靠系统评价。
  • 不可靠最常见原因为缺乏证据表明进行了相关研究的全面文献检索(196篇中149篇,76.0%)。

关键数值与推荐

  • 可靠系统评价需满足全部以下标准:定义研究选择的纳入标准;描述进行全面的文献检索;报告评估纳入研究的偏倚风险;描述对任何Meta分析使用适当方法;结论与评价发现一致。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Patient care and clinical practice guidelines should be informed by evidence from reliable systematic reviews. The reliability of systematic reviews related to forthcoming guidelines for retina and vitreous conditions is unknown. OBJECTIVES: To summarize the reliability of systematic reviews on interventions for 7 retina and vitreous conditions, describe characteristics of reliable and unreliable systematic reviews, and examine the primary area in which they appeared to be lacking. DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional study of systematic reviews was conducted. Systematic reviews of interventions for retina- and vitreous-related conditions in a database maintained by the Cochrane Eyes and Vision United States Satellite were identified. Databases that the reviewers searched, whether any date or language restrictions were applied, and bibliographic information, such as year and journal of publication, were documented. The initial search was conducted in March 2007, and the final update was performed in July 2018. The conditions of interest were age-related macular degeneration; diabetic retinopathy; idiopathic epiretinal membrane and vitreomacular traction; idiopathic macular hole; posterior vitreous detachment, retinal breaks, and lattice degeneration; retinal and ophthalmic artery occlusions; and retinal vein occlusions. The reliability of each review was evaluated using prespecified criteria. Data were extracted by 2 research assistants working independently, with disagreements resolved through discussion or by 1 research assistant with verification by a senior team member. MAIN OUTCOMES AND MEASURES: Proportion of reviews that meet all of the following criteria: (1) defined eligibility criteria for study selection, (2) described conducting a comprehensive literature search, (3) reported assessing risk of bias in included studies, (4) described using appropriate methods for any meta-analysis performed, and (5) provided conclusions consistent with review findings. RESULTS: A total of 327 systematic reviews that addressed retina and vitreous conditions were identified; of these, 131 reviews (40.1%) were classified as reliable and 196 reviews (59.9%) were classified as not reliable. At least 1 reliable review was found for each of the 7 retina and vitreous conditions. The most common reason that a review was classified as not reliable was lack of evidence that a comprehensive literature search for relevant studies had been conducted (149 of 196 reviews [76.0%]). CONCLUSION AND RELEVANCE: The findings of this study suggest that most systematic reviews that addressed interventions for retina and vitreous conditions were not reliable. Systematic review teams and guideline developers should work with information professionals who can help navigate sophisticated and varied syntaxes required to search different resources.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Le JT, Qureshi R, Twose C, et al. Evaluation of Systematic Reviews of Interventions for Retina and Vitreous Conditions. JAMA Ophthalmol. 2019. PMID: 31600387. doi:10.1001/jamaophthalmol.2019.4016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。